Last reviewed · How we verify
use of GABAergic-drugs
use of GABAergic-drugs is a Small molecule drug developed by Ente Ospedaliero Ospedali Galliera. It is currently in Phase 1 development.
At a glance
| Generic name | use of GABAergic-drugs |
|---|---|
| Sponsor | Ente Ospedaliero Ospedali Galliera |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Awareness Neuraxial Versus General Anesthesia in Frail Patients Undergoing Laparoscopic or Robotic Abdominopelvic Surgery. (NA)
- Optimistic and Pessimistic Dopamine Signals in the Human Brain: a Mapping and Modelling Study in Health and Parkinson's Disease
- Cervical Traction to Reduce Gabaergic Medication Use for Neuropathic Itch (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- use of GABAergic-drugs CI brief — competitive landscape report
- use of GABAergic-drugs updates RSS · CI watch RSS
- Ente Ospedaliero Ospedali Galliera portfolio CI
Frequently asked questions about use of GABAergic-drugs
What is use of GABAergic-drugs?
use of GABAergic-drugs is a Small molecule drug developed by Ente Ospedaliero Ospedali Galliera.
Who makes use of GABAergic-drugs?
use of GABAergic-drugs is developed by Ente Ospedaliero Ospedali Galliera (see full Ente Ospedaliero Ospedali Galliera pipeline at /company/ente-ospedaliero-ospedali-galliera).
What development phase is use of GABAergic-drugs in?
use of GABAergic-drugs is in Phase 1.
Related
- Manufacturer: Ente Ospedaliero Ospedali Galliera — full pipeline
- Compare: use of GABAergic-drugs vs similar drugs
- Pricing: use of GABAergic-drugs cost, discount & access